Answer
Yes, dostarlimab can cause immune-related hepatitis.
Sources for this answer
- JEMPERLI 500 mg concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.4 Special warnings and precautions for use · Version 14Document updated
Sources checked